First leg clot size and long-term risk
Part of Heart & circulation clinical trials.
This study looks at how the size and location of a first-time leg blood clot affects the risk of long-term problems like chronic pain or swelling. You may join if you have a new, symptomatic clot in one leg and haven't had one before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have a confirmed blood clot in your leg that is causing symptoms (like pain or swelling). It can be in one leg only.
- You must not have had a blood clot in your leg before.
- You cannot be pregnant or breastfeeding.
- You should not have been on blood thinners for more than 5 days already.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a procedure that removes blood clots from deep veins in the leg (aspiration) combined with blood thinners versus blood thinners alone. The goal is to see if removing the clot helps prevent long-term leg swelling and complications.
This registry collects information from people who have a blood clot in a leg or a clot in the lung. It helps researchers understand how these conditions are treated in real life.
This study tests a new way to treat long-standing blood clots in the leg using ultrasound waves and a balloon procedure. It aims to improve blood flow and reduce symptoms like swelling and pain for people who haven't gotten better with standard treatments.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This study looks at people having their first blood clot in the leg and how it can affect them long-term. It may help doctors better predict complications and improve follow-up care after an emergency visit.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
Hear when a new Postthrombotic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.